Introduction {#s1}
============

Obesity is a major global health problem, which affects people in developed and developing countries [@pone.0058272-Kannel1]--[@pone.0058272-Consultation1]. Approximately 250 million adults suffer from obesity [@pone.0058272-Kuczmarski1], [@pone.0058272-Seidell1]. According to surveys, the age-adjusted prevalence of obesity for males is rapidly increasing in Taiwan from 10.5% to 15.9% from 1993 to 1996 and from 2000 to 2001 [@pone.0058272-Chu1]. Obesity is also associated with numerous chronic health conditions or diseases, such as diabetes, hypertension, and cardiovascular diseases [@pone.0058272-Must1], [@pone.0058272-Kopelman1].

The commonly used indicators for obesity are body mass index (BMI), waist circumference (WC), waist-height ratio (WHtR), and waist-to-hip ratio (WHR). Bioelectrical impedance analysis (BIA) produces a close estimate of fat mass in a wide range of body compositions [@pone.0058272-Deurenberg1]. BIA is a non-invasive measurement of body composition and particularly useful in large epidemiologic studies. BIA has also many advantages compared with other methods because it is inexpensive, simple, fast, safe, portable, and easy to perform, as well as requires minimum operator training [@pone.0058272-Houtkooper1], [@pone.0058272-Roubenoff1]. Instead of using the common indicators for obesity such as BMI, WC, WHtR, and WHR, BIA is used to determine the body fat percentage (%BF). Other obesity indicators do not measure %BF because of their inability to distinguish fat from muscle. For instance, a study has found that adiponectin, a substance secreted by the adipose tissue, can regulate energy homeostasis as well as glucose and lipid metabolism [@pone.0058272-Yamauchi1]. Adiponectin is also involved in inhibiting inflammatory responses through its inhibitory functions [@pone.0058272-Yokota1]. Another study has revealed that adiponectin is also associated with body fat distribution [@pone.0058272-Staiger1], even in normal-weight subjects [@pone.0058272-Festen1]. Furthermore, %BF is more effective in detecting individuals with disturbed glucose tolerance, risk of cardiometabolic disease, early stage cardiovascular disease, and breast cancer survival rate [@pone.0058272-GmezAmbrosi1]--[@pone.0058272-Dee1]. Thus, %BF should be determined.

A previous study confirmed the validity of BIA in estimating %BF compared with dual-energy X-ray absorptiometry (DXA) [@pone.0058272-Roubenoff1]. DXA is a valid method to aid studies on obesity [@pone.0058272-Evans1]. However, radiation emitted during DXA measure has been reported in previous studies [@pone.0058272-DeSchepper1]--[@pone.0058272-Xu1]. The effective radiation dose of DXA is among the lowest from the commonly used medical X-ray examinations and lower than a standard chest X-ray [@pone.0058272-DeSchepper1]. Therefore, DXA is appropriate for clinical patient treatment; however, unlike BIA, DXA limits epidemiological studies and wide application. BIA is a good predictor of DXA-derived fat-free mass (*r* = 0.85 to 0.88) [@pone.0058272-Roubenoff1]. BIA measurements are determined by the resistance of the body to electrical current flow between points of contact on the body and correlates well with total body water measurements [@pone.0058272-Erceg1]. BIA exhibits greater resistance to electrical current flow in fat tissues than fat-free tissues because of their differences in water content.

Several studies have been conducted on the validation of BIA in the estimation of %BF compared with DXA [@pone.0058272-Roubenoff1], [@pone.0058272-Lazzer1]--[@pone.0058272-Kim1]. However, only two %BF studies, in which BIA was used, has been conducted among Asian adults. One study [@pone.0058272-Sato1] involves a cross-sectional investigation stratified by gender and the other [@pone.0058272-Kim1] uses a longitudinal study on Korean women. Most of the studies have been conducted on Caucasians [@pone.0058272-Lazzer1], [@pone.0058272-Shafer1], [@pone.0058272-Verdich1]--[@pone.0058272-Neovius1], [@pone.0058272-LloretLinares1] and African-Americans [@pone.0058272-Newton1], [@pone.0058272-NewtonJr1]. Several studies have considered only women [@pone.0058272-Newton1], [@pone.0058272-Verdich1], [@pone.0058272-Neovius1], [@pone.0058272-NewtonJr1], [@pone.0058272-Kim1] or adolescents [@pone.0058272-Lazzer1], [@pone.0058272-Newton1]. Longitudinal studies [@pone.0058272-Verdich1], [@pone.0058272-LloretLinares1]--[@pone.0058272-Frisard1] have also been performed, in which two studies have used weight-loss programs without randomization [@pone.0058272-LloretLinares1], [@pone.0058272-Kim1]. The sample sizes used in most of these studies are small, which range from 53 to 136 subjects [@pone.0058272-Lazzer1]--[@pone.0058272-Sato1], [@pone.0058272-BosyWestphal1]--[@pone.0058272-NewtonJr1]. Only two studies have considered a large sample size (*n*\>500) [@pone.0058272-Roubenoff1], [@pone.0058272-LloretLinares1]. The sample sizes of previous longitudinal studies [@pone.0058272-Verdich1], [@pone.0058272-LloretLinares1]--[@pone.0058272-Frisard1] ranged from 34 to 105 subjects. The validation of the hand-to-foot BIA with simple frequency is also limited [@pone.0058272-Sato1], [@pone.0058272-Neovius1].

Addressing questions on whether or not BIA is a valid method for monitoring the changes in %BF to evaluate the effects of weight-loss programs is highly important because of the increasing need for an administrable and accurate instrument in weight-loss programs.

The current study aimed to compare estimates of %BF by performing BIA and DXA in a sample of obese or overweight Chinese adults who participated in a weight-loss intervention trial in Taiwan. This study also determined whether or not BIA is a valid measurement tool for weight-loss programs.

Materials and Methods {#s2}
=====================

Subjects {#s2a}
--------

The study population consisted of obese or overweight individuals who are in good health and reside in the Taichung city, which is located in west-central Taiwan. Data were collected from participants of a randomized intervention study, in which the effects of three weight-loss programs were evaluated. The duration of the intervention programs was six months. Assessments were made at the baseline and six months from the baseline. The subjects were recruited during community screening activities, advertisements, and Internet propaganda. Before randomization, 240 obese or overweight adults (age \>40 years) at the baseline were recruited according to either one of the two criteria of obesity: (1) BMI recommended by the Department of Health, Executive Yuan, R.O.C [@pone.0058272-Department1] and (2) WC recommended by an Asian modification for the (central) obesity by National Cholesterol Education program Adult Treatment Panel-III (NCEP ATP-III) definition of metabolic syndrome (MetS) [@pone.0058272-Crepaldi1]. The BMI cut-off points for obese and overweight were 27 and 24 kg/m^2^, respectively. The WC cut-off points for (central) obesity were 90 and 80 cm in males and females, respectively. Under this condition, several subjects with (central) obesity determined by WC at the baseline may have a normal BMI. Complete data included 189 subjects (73 males and 116 females); 51 subjects were removed because of missing or incomplete data at the end of the study. The study was approved by the Human Research Committee of the China Medical University Hospital. Written informed consent was obtained from each participant.

Anthropometric measurements {#s2b}
---------------------------

Weight and height were measured using an auto-anthropometer (Super-View, HW-666, Taipei, Taiwan) and estimated to the nearest 0.1 kg and 0.1 cm, respectively (the subjects were shoeless and wore light clothing). BMI was calculated as weight (kg) divided by the square of height (m). %BF was determined by performing BIA and DXA.

BIA {#s2c}
---

A body composition analyzer (Tanita BC-418, Tanita Corp., Tokyo, Japan) was used to estimate %BF. Eight polar electrodes were applied on both feet and both hands. The electric current was then supplied from the electrodes on the tips of the toes and fingers and the voltage was measured on the heel of both feet and the thenar side of both hands. The analyzer provided a complete %BF analysis, including %BF, in less than 30 s. The analyzer can be used for subjects with weights of up to 200 kg and measure the body composition by using a constant current source at a frequency current of 50 kHz (500 µÅ). Before the assessment, the participants were subjected to a 12 h fasting period and instructed to avoid heavy physical activity, alcohol ingestion, and diuretic intake. After the assessors manually documented the weight of clothes, body type, age, and height into the system, the subjects in light clothing removed their shoes, wiped their feet, and stood on the weighing platform without bending their knees. Measurement began when the subjects placed their hands on the grips. Thereafter, the process was completed. The BIA variable used in the present study was %BF~BIA~.

DXA {#s2d}
---

Fat mass was measured using DXA (GE-LUNAR DPX PRO, Lunar Corp., Madison, WI, USA). Data were analyzed using the enCORE2004 software, version 8.60.006 at coefficient of variation \<1%. The subjects were subjected to DXA in their underwear, without any metal items. The operator performed a whole-body scan on each subject as he/she lies in a supine position. Whole-body composition analysis provided data on different regions of interest, including the trunk, arms, and legs. Equipment was calibrated each day by using a standardized phantom. The DXA variable used in the present study was %BF~DXA~.

Statistical analysis {#s2e}
--------------------

Descriptive data at the baseline, the endpoint, and in changes stratified by gender were presented as mean (SD). The methods used to assess the relationships between %BF~BIA~ and %BF~DXA~ stratified by gender at different stages were Pearson\'s correlation coefficients (*r*), Bland-Altman analyses, and multiple regression analyses. *r* among BMI, %BF~BIA~, and %BF~DXA~ were also calculated. The level of correlation was considered low or weak when *r*≤0.35, moderate when *r* = 0.36 to 0.67, and strong when *r* = 0.68 to 1.0 [@pone.0058272-Taylor1]. The mean bias and 95% limits of agreement between %BF~BIA~ and %BF~DXA~ were estimated in the Bland-Altman plots and reported by table, with the %BF~DXA~ as the gold standard and %BF~BIA~ as the comparison. Stepwise multiple regression analyses were used to identify the significant predictors of differences between %BF~BIA~ and %BF~DXA~. A significant explanatory variable for this difference indicates that the measurement error systematically varied according to the values of this explanatory variable. Thus, the measurement errors were associated with this explanatory variable. Under this condition, the explanatory variable is a measurement bias. However, an explanatory variable is not a significant predictor, indicating that the measurement error is random according to this explanatory variable. The higher *R* ^2^ and the greater magnitude of the difference between %BF~BIA~ and %BF~DXA~ can be explained by the explanatory variables. The first model includes %BF~DXA~, whereas the second model considers %BF~DXA~, BMI, and age. All of the analyses were performed using SAS version 9.2 (SAS Institute, Cary, North Carolina). All two-sided p-values \<0.05 were considered statistically significant.

Results {#s3}
=======

Study subject characteristics {#s3a}
-----------------------------

[Table 1](#pone-0058272-t001){ref-type="table"} presents the baseline characteristics and the subjects\' subsequent changes by gender. Their ages ranged from 41 to 74 years. Based on BMI, male subjects who were obese, overweight, and had normal weight at the baseline were 46.6%, 52.1%, and 1.4%, respectively. In females, the corresponding percentages were 38.8%, 50.9%, and 10.3%, respectively. Females had a higher percentage of total body fat in BIA and DXA. During the intervention period, decreases in weight, BMI, and %BF~DXA~ were observed, but a slight increase in %BF was found in BIA at the endpoint. After the intervention program, 13.76% of the subjects had normal weight, in which eight were male and eight were female. For both males and females, BIA underestimated %BF with the greatest difference at the baseline and the least difference at the endpoint.

10.1371/journal.pone.0058272.t001

###### Subject characteristics.

![](pone.0058272.t001){#pone-0058272-t001-1}

  Gender          Variable       Baseline     Endpoint      Change
  ------------ --------------- ------------ ------------ ------------
  **Male**       AGE (year)     52.8(7.0)                
  (n = 73)       HEIGHT (cm)    68.0(6.0)                
                 WEIGHT (kg)    78.3(10.3)   76.5(10.6)    1.9(2.8)
                BMI (kg/m^2^)   27.7(2.6)    27.0(2.7)    0.68(1.1)
                %BF~BIA~ (%)    25.3(4.4)    26.8(5.8)    −1.5(4.7)
                %BF~DXA~ (%)    29.9(3.4)    28.1(4.5)     1.7(2.6)
                  Δ%BF (%)       4.6(3.6)     1.4(4.5)     3.2(4.1)
                MEAN %BF (%)    27.6(3.5)    27.4(4.7)    0.12(3.2)
                  ICC (%BF)        0.58         0.63         0.41
                                                         
  **Female**     AGE (year)     52.4(6.9)                
  (n = 116)      HEIGHT (cm)    155.5(5.5)               
                 WEIGHT (kg)    65.4(8.2)    62.7(8.1)     2.7(3.4)
                BMI (kg/m^2^)   27.0(3.0)    25.9(3.1)     1.1(1.4)
                %BF~BIA~ (%)    36.6(4.4)    37.3(5.5)    −0.68(4.3)
                %BF~DXA~ (%)    41.7(4.6)    39.4(5.5)     2.3(3.2)
                  Δ%BF (%)       5.1(3.8)     2.2(4.2)     3.0(4.0)
                MEAN %BF (%)    39.1(4.1)    38.3(5.1)    0.80(3.2)
                  ICC (%BF)        0.64         0.71         0.45

Values are mean(SD); BMI, body mass index; %BF, percentage of body fat; DXA.

dual energy x-ray absorptiometry; BIA, bioelectrical impedance analysis equipment.

Δ%BF, mean difference between methods (%BFDXA-%BFBIA); MEAN %BF mean of methods (%BFDXA, %BFBIA). ICC, intraclass correlation coefficient.

Agreement between methods {#s3b}
-------------------------

For males or females, %BF and BMI were significantly correlated ([Table 2](#pone-0058272-t002){ref-type="table"}). Three strong *r* were observed in females, particularly between %BF~BIA~ and BMI, between %BF~BIA~ and %BF~DXA~ at the endpoint, as well as between %BF~DXA~ and BMI in changes. Agreement between these methods is shown in [Table 3](#pone-0058272-t003){ref-type="table"} and [Figure 1](#pone-0058272-g001){ref-type="fig"} by using the Bland-Altman plots with mean bias and 95% limits of agreement. For both males and females, the mean differences at the endpoint were the smallest compared with the baseline and in changes ([Table 3](#pone-0058272-t003){ref-type="table"}). The slopes in [Figure 1](#pone-0058272-g001){ref-type="fig"} show that the correlation between the differences in DXA and BIA, as well as the mean %BF measured using both methods was stronger in males than that in females at the baseline, the endpoints, and in change. The lines at the endpoint were more parallel to the *x*-axis than those at the baseline and in changes in males and females. At the endpoint, the magnitude of the underestimation of %BF based on BIA decreased compared with that at the baseline. [Table 3](#pone-0058272-t003){ref-type="table"} shows that the mean difference between %BF~DXA~ and %BF~BIA~ was larger in females than that in males at the baseline and the endpoint, but slightly smaller in males than that in females at changes. [Table 4](#pone-0058272-t004){ref-type="table"} reveals that the magnitude of difference between %BF~DXA~ and %BF~BIA~ based on DXA, age, and BMI was greater in females than that in males (*R* ^2^ ~female~  = 0.23 vs. *R* ^2^ ~male~  = 0.05 at the baseline; *R* ^2^ ~female~  = 0.13 vs. *R* ^2^ ~male~  = 0.03 at the endpoint; and *R* ^2^ ~female~  = 0.09 vs. *R* ^2^ ~male~  = 0.01 in change).

![Bland-Altman plots with mean bias (central line) and 95% limits of agreement for comparing %BF~BIA~ and %BF~DXA~ at the baseline, endpoint, and in changes.\
The central line represents the mean bias between %BF~BIA~ and %BF~DXA~; the outer lines represent 95% limits of agreement.](pone.0058272.g001){#pone-0058272-g001}

10.1371/journal.pone.0058272.t002

###### Pearson correlation matrix for body fat percentage. and anthropometric variables.

![](pone.0058272.t002){#pone-0058272-t002-2}

              Male (n = 73)   Female (n = 116)         
  ---------- --------------- ------------------ ------ ------
  Baseline                                             
  BMI             0.61              0.54         0.65   0.59
  %BF~BIA~                          0.60                0.64
  Endpoint                                             
  BMI             0.65              0.65         0.81   0.66
  %BF~BIA~                          0.65                0.71
  Change                                               
  BMI             0.58              0.65         0.58   0.79
  %BF~BIA~                          0.48                0.47

All are significant at the p\<0.001 level.

10.1371/journal.pone.0058272.t003

###### Mean differences and 95% limits of agreement between %BF~BIA~ and %BF~DXA~ using Bland-Altman analysis.

![](pone.0058272.t003){#pone-0058272-t003-3}

              Male (n = 73)   Female (n = 116)        
  ---------- --------------- ------------------ ----- --------------
  Baseline         4.6          −2.4 to 11.7     5.1   −2.4 to 12.7
  Endpoint         1.4          −7.4 to 10.2     2.2   −6.1 to 10.4
  Change           3.2          −4.8 to 11.3     3.0   −4.8 to 10.7

10.1371/journal.pone.0058272.t004

###### Regression analysis of the difference between DXA and BIA.

![](pone.0058272.t004){#pone-0058272-t004-4}

  Δ%BF    Explanatory variables   Parameter Estimate   p value   R^2^
  ------ ----------------------- -------------------- --------- -------
                %BF~DXA~                 0.53          \<.001    23.1%
                   BMI                   0.72          \<.001   
                   AGE                  −0.04           0.51    

  Endpoint    %BF ~DXA~   0.18     0.13    3.3%
  ---------- ----------- ------- -------- -------
              %BF ~DXA~   0.59    \<.001   24.1%
                 BMI      −0.96   \<.001  
                 AGE      −0.16    0.02   

  Change    %BF ~DXA~   0.15    0.41    0.98%
  -------- ----------- ------ -------- -------
            %BF ~DXA~   0.72   0.002    20.7%
               BMI      −2.0   \<.001  
               AGE      0.11    0.10   

  Female                                
  -------- ----------- ------- -------- -------
            %BF ~DXA~   0.65    \<.001   40.4%
               BMI      −0.62   \<.001  
               AGE      0.08     0.05   

  Endpoint    %BF ~DXA~   0.28    \<.001   13.5%
  ---------- ----------- ------- -------- -------
              %BF ~DXA~   0.69    \<.001   48.8%
                 BMI      −1.1    \<.001  
                 AGE      −0.01    0.83   

  Change    %BF ~DXA~   0.38   \<.001   9.4%
  -------- ----------- ------ -------- -------
            %BF ~DXA~   0.99   \<.001   25.4%
               BMI      −1.8   \<.001  
               AGE      0.08    0.11   

[Table 4](#pone-0058272-t004){ref-type="table"} also shows the statistical analysis for the regression of the differences between DXA and BIA on explanatory variables at the baseline, the endpoint, and in changes stratified by gender. In males, %BF~DXA~ alone was not a significant predictor for Δ%BF at the baseline, the endpoint, and in changes. The corresponding percentages of variation for the differences between DXA and BIA explained by %BF~DXA~ were 4.9%, 3.3%, and 0.98% at the baseline, the endpoint, and in changes, respectively. BMI and age resulted in significant %BF~DXA~ in all of the models. In addition to %BF~DXA~, BMI was a significant predictor in all of the models. Age was only significant in the model at the endpoint. The corresponding percentages of variation for the difference between DXA and BIA based on %BF~DXA~, BMI, and age were 23.1%, 24.1%, and 20.7%, respectively. In females, %BF~DXA~ was a significant predictor for Δ%BF at the baseline, the endpoint, and in changes. The corresponding percentages of variation for the difference between DXA and BIA based on %BF~DXA~ at the baseline, the endpoint, and in changes were 22.8%, 13.5%, and 9.4%, respectively. %BF~DXA~ remained significant in all of the models when BMI and age were considered. In addition to %BF~DXA~, BMI was significant in all of the models. The corresponding percentages of variation for the differences between DXA and BIA based on %BF~DXA~, BMI, and age were 40.4%, 48.8%, and 25.4%, respectively.

Discussion {#s4}
==========

The current study showed that BIA is a useful measuring tool for the assessment of %BF at the endpoint in individuals with normal weight, overweight, or obesity, but provides less accurate predictions of %BF in changes during the weight-loss intervention programs. This result was demonstrated by the strong correlation between %BF parameters determined by BIA and DXA. Our Bland-Altman agreement analysis showed that BIA underestimated %BF. This bias increased as %BF~DXA~ increased. The variation in percentage of this bias, which is associated with %BF~DXA~, was significantly higher in females than that in males. Therefore, caution should be used when interpreting the changes in %BF between the baseline and the endpoint when BIA is used in clinical practice, particularly in obese or overweight Chinese females.

Several studies have compared BIA with DXA as the reference method. However, results are mixed. In general, when assessing %BF in cross-sectional studies, some studies have reported that BIA overestimates %BF or fat mass weight [@pone.0058272-Shafer1], [@pone.0058272-LloretLinares1], [@pone.0058272-Kim1], whereas others have revealed that BIA underestimates %BF or fat mass weight [@pone.0058272-Lazzer1], [@pone.0058272-Newton1], [@pone.0058272-Verdich1], [@pone.0058272-NewtonJr1], which is also found in the present study. Similarly, among these longitudinal studies, some have underestimated %BF at the baseline, at the endpoint, and in change, whereas some studies have overestimated %BF at different time points. However, results in previous studies are difficult to compare with those in the present study because various devices were used, such as foot-to-foot BIA [@pone.0058272-Lazzer1], [@pone.0058272-LloretLinares1], devices with adhesive tape [@pone.0058272-Lazzer1], [@pone.0058272-Newton1], [@pone.0058272-Verdich1], [@pone.0058272-NewtonJr1], [@pone.0058272-Aslam1], [@pone.0058272-Kim1], or multi-frequency devices [@pone.0058272-Shafer1]. Our results are in agreement with those in two cross-sectional studies, in which a BIA-type device, namely, the hand-to-foot BIA with simple frequency, was used. In particular, similar estimates of %BF have been reported [@pone.0058272-Sato1], [@pone.0058272-Neovius1]. In one of these two studies, 72 obese Japanese adults (age  = 51.2±9.4 years; BMI  = 28.0±2.2 kg/m^2^) were considered, in which body fat at the extremities, trunk, and total body was determined using DXA and single-frequency BIA equipment (BC-118, Tanita Corp., Tokyo, Japan) [@pone.0058272-Sato1]. The accuracy of the estimated %BF value in the trunk was lower than that of the total body. SF-BIA reveals an underestimated %BF in the total body in males. In another study, Neovius et al. also examined the accuracy of SF-BIA (BC-418, Tanita Corp., Tokyo, Japan) in 136 obese Swedish women (age  = 48.1±7.7 years; BMI: 30.4±2.9 kg/m^2^) [@pone.0058272-Neovius1]. The BIA equipment used has revealed an underestimated %BF, which is consistent with our findings. Two possible reasons can explain this underestimated result. First, 50 kHz of current can pass through extracellular and intracellular spaces, and thus individual hydration states can be used as a factor of error. Second, the body position, particularly during standing, can change the fluid distribution, which can influence the measurement of resistance.

Our regression analysis indicated that a higher %BF~DXA~ increased the biases between DXA and BIA at the baseline, the endpoint, and in changes in males and females, and a higher BMI decreased the biases, except BMI at the baseline in males. These results are consistent with those of Neovius et al. [@pone.0058272-Neovius1], in which the variation in percentages for the differences between DXA and BIA based on %BF~DXA~ was similar to that in our study at the baseline in females. However, Neovius only evaluated the performance of BIA compared with DXA in centrally obese women by using a cross-sectional study [@pone.0058272-Neovius1]. Our findings further revealed the changes in obese individuals during the intervention programs. The results in males and females with normal weight, overweight, or obesity were also reported. Our findings indicated that biases were significantly greater in females compared with those in males, which is attributed to the regional differences in the fat distribution in the body.

Few studies have investigated this issue in Asia. In addition to the findings in the previous Japanese report [@pone.0058272-Sato1], a Korean longitudinal study compared the body composition assessments in terms of BIA and DXA before and after a six-week herbal diet intervention program in 50 pre-menopausal women (age  = 30.6±6.2 years; BMI  = 31.7±3.8 kg/m^2^) [@pone.0058272-Kim1]. In these two studies, *r* between %BF~BIA~ and %BF~DXA~ is significant [@pone.0058272-Sato1], [@pone.0058272-Kim1], which is consistent with our findings. However, *r* is slightly higher in Japanese (*r*\>0.70, p\<0.01) and Koreans before the six-week intervention (*r* = 0.79, *p*\<0.05) compared with that in our findings (*r* = 0.64 at the baseline; *r* = 0.71 at the endpoint, p\<0.001) in the female group. Differences between BIA and DXA measurements were also observed in these two studies [@pone.0058272-Sato1], [@pone.0058272-Kim1]. In our study, BIA underestimated %BF of the total body in both genders, but was only observed in males in the previous Japanese study [@pone.0058272-Sato1]. By contrast, BIA overestimated the total body fat by 2.54 kg and changes in %BF compared with DXA (p\<0.001) in the Korean study [@pone.0058272-Kim1]. Thus, we need a larger sample size to obtain more accurate information in future studies for a better understanding of the differences between BIA and DXA.

The present study has both strengths and weaknesses. For the strengths, our sample size was larger compared with previous longitudinal studies or randomized control trials that having size of samples from 34 to 136. Due to the larger sample size, an evaluation stratified by genders was available in the present study. Our study also evaluated the accuracy of BIA among obese or overweight subjects, and the endpoint of the study allowed us to estimate the accuracy of BIA among subjects with normal weight, overweight, or obesity after participating in the weight-loss programs. The current study also described the subjects at different periods; thus, we can determine the accuracy of BIA in weight changes during the intervention programs.

The current study also has several limitations. The use of pencil-beam DXA as the gold standard was the first limitation because the device is an older generation of DXA instrument. A previous study compared the %BF measurements between pencil-beam and fan-beam DXA [@pone.0058272-Ellis1]. Results showed that the mean differences were --0.7% for %fat and 6.4% for fat in kg, indicating that the two DXA technologies can be considered equivalent. We also used the same instrument in %BF during the entire intervention period, which prevented extra variations and minimized bias to evaluate the accuracy of BIA measurements. Second, we only studied Chinese adults. Ethnic- and age-related differences in the accuracy of BIA measurements likely exist. Studies of other ethnic groups, children, or adolescents may yield different results. Third, we did not include a severely obese group; we only tested the accuracy in the overall excess weight. Therefore, our results were limited to a severely obese cohort.

In conclusion, BIA is useful and relatively cheap equipment in the assessment of obesity in both genders. During the weight-loss program period, we found that BIA provides a valid estimate at the endpoint, particularly in individuals with normal weight, overweight, or obesity, but provides less accurate predictions of %BF at the baseline in obese individuals or in weight changes during the intervention programs. This study is the first to validate BIA in a randomized control trial of weight loss in Chinese subjects. Our findings indicate that BIA underestimated %BF. The difference between DXA and BIA is likely to increase as an individual\'s %BF~DXA~ increases. Thus, this study should be replicated using other ethnic and age groups with a severely obese cohort.
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